Insight Molecular Diagnostics Inc. Share Price

Insight Molecular Diagnostics Inc. Share Price

NASDAQ: IMDX | Micro Cap
$2.97
-$0.18 (-5.71%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Insight Molecular Diagnostics Inc. Stock Performance

Open
$3.00
Prev. Close
$3.15
Circuit Range
N/A
Day Range
$2.95 - $3.00
Year Range
$2.42 - $8.49
Volume
1,674
Average Traded
$2.97

Insight Molecular Diagnostics Inc. Share Price Today

As of 31 October 2026, Insight Molecular Diagnostics Inc.'s share price is $2.97. The stock opened at $3.00, compared to its previous close of $3.15. During today's trading session, Insight Molecular Diagnostics Inc.'s share price traded between $2.95 and $3.00, with an average price of $2.98. Over the past 52 weeks, the stock has recorded a high of $8.49 and a low of $2.42. In terms of performance, Insight Molecular Diagnostics Inc.'s share price has declined by 25.00% over the last six months and is down 50.99% on a year-on-year basis.

Insight Molecular Diagnostics Inc. Share Price Chart

Line chart of the Insight Molecular Diagnostics Inc. price trend over the selected period. The price fell overall, ranging from 2.95 to 3.14, ending at 2.97.
$2.95$3.00
L
Show Current Price
H

Insight Molecular Diagnostics Inc. Stock Fundamentals & Key Indicators

Market Cap
$90.51M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.51
Revenue (TTM)
$4.06B
Return On Equity (TTM)
231.74%
Profit Margin
-1236.95%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-3.78%

Insight Molecular Diagnostics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.26$1.14$0.03$0.24
Net Profit-$10.85-$22.96-$4.29-$11.26
Net Profit Margin-4173.08%-2014.04%-14300.00%-4691.67%
Income ChangeN/A-111.61%81.32%-162.47%

Insight Molecular Diagnostics Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$4.06
Net Profit-$50.22
Net Profit Margin-1236.95%
Income ChangeN/A

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Insight Molecular Diagnostics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.37
$2.97
-17.39%
Sep 2026
$3.82
$3.60
-15.81%
Aug 2026
$4.90
$4.27
-8.57%
Jul 2026
$5.74
$4.67
-20.03%
Jun 2026
$6.21
$5.84
-6.41%
May 2026
$3.99
$6.24
+57.58%
Apr 2026
$3.03
$3.96
+20.73%
Mar 2026
$5.83
$3.28
-45.24%
Feb 2026
$6.79
$5.99
-9.79%
Jan 2026
$7.27
$6.64
-11.58%
Dec 2025
$5.81
$7.51
+22.71%
Nov 2025
$5.95
$6.12
+0.99%

IMDX Share Price FAQs